Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

Clinical trial NCT04857112 · COMPLETED

Trial details

NCT number: NCT04857112
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2021-09-29
Primary completion: 2024-09-03
Enrollment: 322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.